X-Elio signs 10-year virtual PPA to supply 245GWh/year from Lorca Solar to four pharmaceutical companies
Type: Ppa · Technology: Solar · Country: Spain · Capacity: 369 MW · Announced: 2025-02-05
Spanish renewables developer X-Elio signed a 10-year virtual power purchase agreement to supply 245 GWh of clean energy annually (sourced from 35% of the Lorca Solar 369 MW project) to a cohort of four pharmaceutical companies — Thermo Fisher Scientific, Haleon, Gilead Sciences and GSK — under Schneider Electric's Energize programme.
Counterparties
- Gilead Sciences, Inc (Offtaker)
- Haleon (Offtaker)
- Thermo Fisher Scientific (Offtaker)
- X-Elio (Developer)
- Schneider Electric Sustainability Business (Partner)
- GlaxoSmithKline plc (Offtaker)
📈 The Sherpa Signal — one notable infrastructure deal a day.